Efficacy News and Research

RSS
Academy of Finland funds projects for vaccine and drug development for COVID-19

Academy of Finland funds projects for vaccine and drug development for COVID-19

Study assesses impact of anti-SARS-CoV-2 convalescent plasma in COVID-19 disease

Study assesses impact of anti-SARS-CoV-2 convalescent plasma in COVID-19 disease

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

Far-UVC light can efficiently and safely kill airborne coronaviruses

Far-UVC light can efficiently and safely kill airborne coronaviruses

Statin therapy linked to lower death rate in hospitalized patients with COVID-19

Statin therapy linked to lower death rate in hospitalized patients with COVID-19

New findings provide a glimpse of daunting experiences faced by hospitals in fight against COVID-19

New findings provide a glimpse of daunting experiences faced by hospitals in fight against COVID-19

Standard smartphone technology can be adapted to image skin lesions

Standard smartphone technology can be adapted to image skin lesions

C-Path announces launch of CURE Drug Repurposing Collaboratory

C-Path announces launch of CURE Drug Repurposing Collaboratory

Novel treatment provides cardioprotection after heart attack in animal models

Novel treatment provides cardioprotection after heart attack in animal models

UK announces research partnership with Atomwise to explore potential COVID-19 therapies

UK announces research partnership with Atomwise to explore potential COVID-19 therapies

FDA approved drugs active against COVID-19

FDA approved drugs active against COVID-19

First clinical trial in South Africa for Covid-19 vaccine begins

First clinical trial in South Africa for Covid-19 vaccine begins

Study: Increased use of human antibiotics on rice crops may fuel antibiotic resistance

Study: Increased use of human antibiotics on rice crops may fuel antibiotic resistance

Jubilant Therapeutics announces preclinical data of dual LSD1 and HDAC6 inhibitor at AACR 2020

Jubilant Therapeutics announces preclinical data of dual LSD1 and HDAC6 inhibitor at AACR 2020

Characterizing SARS-CoV-2 convalescent plasma

Characterizing SARS-CoV-2 convalescent plasma

Growth, adaptation and neutralization of SARS-CoV-2 with acute-phase serum

Growth, adaptation and neutralization of SARS-CoV-2 with acute-phase serum

Three vaccine candidates race to combat SARS-CoV-2

Three vaccine candidates race to combat SARS-CoV-2

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Novel vaccine platform against COVID-19 based on engineered human mesenchymal stem cells

Novel vaccine platform against COVID-19 based on engineered human mesenchymal stem cells

Reassuring news on the Oxford vaccine (AZD1222) against SARS-CoV-2

Reassuring news on the Oxford vaccine (AZD1222) against SARS-CoV-2

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.